Survival advantage of patients with SHDT over patients with CT (unmutated patients only). Survival from diagnosis (A; n = 58), from time of study entry (B; n = 58), and from time of symptomatic disease (C; n = 50) of patients with unmutated VH treated with SHDT (- - -) and CT (—).